Have a personal or library account? Click to login
Bayesian Modeling to Project the National and Regional Burden of Rheumatic Heart Disease in Brazil Till 2050 Cover

Bayesian Modeling to Project the National and Regional Burden of Rheumatic Heart Disease in Brazil Till 2050

Global Heart
Volume 20 (2025): Issue 1
By: Pedro Rafael Vieira de Oliveira Salerno,  Antoinette Cotton,  Zhou Chen,  Vaibhav Shah,  Gabriel Tensol Rodrigues Pereira,  Sadeer Al-Kindi,  Craig Sable,  Antonio Luiz Pinho Ribeiro,  Andrea Z. Beaton,  Salil V. Deo and  Bruno Ramos Nascimento  
Open Access
|Dec 2025

References

  1. 1Rwebembera J, Nascimento BR, Minja NW, de Loizaga S, Aliku T, Dos Santos LPA, et al. Recent advances in the rheumatic fever and rheumatic heart disease continuum. Pathogens. 2022;11(2):179. DOI: 10.3390/pathogens11020179
    Back to article
  2. 2Dougherty S, Beaton A, Nascimento BR, Zühlke LJ, Khorsandi M, Wilson N. Prevention and control of rheumatic heart disease: overcoming core challenges in resource-poor environments. Ann Pediatr Cardiol. 2018;11(1):68–78. DOI: 10.4103/apc.APC_135_17
    Back to article
  3. 3Ghamari S-H, Abbasi-Kangevari M, Saeedi Moghaddam S, Aminorroaya A, Rezaei N, Shobeiri P, et al. Rheumatic heart disease is a neglected disease relative to its burden worldwide: findings from Global Burden of Disease 2019. J Am Heart Assoc. 2022;11(13):e025284. DOI: 10.1161/JAHA.122.025284
    Back to article
  4. 4Mensah GA, Fuster V, Murray CJL, Roth GA, Global Burden of Cardiovascular Diseases and Risks Collaborators. Global burden of cardiovascular diseases and risks, 1990–2022. J Am Coll Cardiol. 2023;82(25):2350–2473. DOI: 10.1016/j.jacc.2023.11.007
    Back to article
  5. 5de Oliveira GMM, Brant LCC, Polanczyk CA, Malta DC, Biolo A, Nascimento BR, et al. Cardiovascular statistics – Brazil 2023. Arq Bras Cardiol. 2024;121(2):e20240079. DOI: 10.36660/abc.20240079
    Back to article
  6. 6Coube M, Nikoloski Z, Mrejen M, Mossialos E. Inequalities in unmet need for health care services and medications in Brazil: a decomposition analysis. Lancet Reg Health Am. 2023;19:100426. DOI: 10.1016/j.lana.2022.100426
    Back to article
  7. 7Brant LCC, Nascimento BR, Teixeira RA, Lopes MACQ, Malta DC, Oliveira GMM, Ribeiro ALP. Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities. Heart. 2020;106(24):1898–1905. DOI: 10.1136/heartjnl-2020-317663
    Back to article
  8. 8de Aquino Xavier RM, Azevedo VMP, Godoy PH, Migowski A, Ribeiro ALP, Chaves RBM, et al. Medium-term outcomes of 78,808 patients after heart valve surgery in a middle-income country: a nationwide population-based study. BMC Cardiovasc Disord. 2017;17(1):302. DOI: 10.1186/s12872-017-0725-9
    Back to article
  9. 9Ribeiro ALP, Gagliardi SPL, Nogueira JLS, Silveira LM, Colosimo EA, Lopes do Nascimento CA. Mortality related to cardiac surgery in Brazil, 2000–2003. J Thorac Cardiovasc Surg. 2006;131(4):907–909. DOI: 10.1016/j.jtcvs.2005.11.022
    Back to article
  10. 10GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–2161. DOI: 10.1016/S0140-6736(24)00757-8
    Back to article
  11. 11Institute for Health Metrics and Evaluation (IHME). Global fertility, mortality, migration, and population forecasts 2017–2100 [Internet]. 2020 [cited 2024 Mar 25]. Available from: http://ghdx.healthdata.org/record/ihme-data/global-population-forecasts-2017-2100
    Back to article
  12. 12Riebler A, Held L. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations. Biom J. 2017;59(3):531–549. DOI: 10.1002/bimj.201500263
    Back to article
  13. 13Bell A. Age period cohort analysis: a review of what we should and shouldn’t do. Ann Hum Biol. 2020;47(2):208–217. DOI: 10.1080/03014460.2019.1707872
    Back to article
  14. 14Longenecker CT. Rheumatic fever in Brazil: what color should it be? Arq Bras Cardiol. 2019;113(3):355–356. DOI: 10.5935/abc.20190178
    Back to article
  15. 15Berwanger O, Santo K. Cardiovascular care in Brazil: current status, challenges, and opportunities. Circulation. 2022;146(6):435–437. DOI: 10.1161/CIRCULATIONAHA.122.059320
    Back to article
  16. 16Harris M, Haines A. Brazil’s Family Health Programme. BMJ. 2010;341:c4945. DOI: 10.1136/bmj.c4945
    Back to article
  17. 17Passos LSA, Nunes MCP, Aikawa E. Rheumatic heart valve disease pathophysiology and underlying mechanisms. Front Cardiovasc Med. 2020;7:612716. DOI: 10.3389/fcvm.2020.612716
    Back to article
  18. 18Roman A. A closer look into Brazil’s healthcare system: what can we learn? Cureus. 2023;15(5):e38390. DOI: 10.7759/cureus.38390
    Back to article
  19. 19do Socorro Candeira Costa M, dos Santos Figueiredo FW. Relationship between income inequality, socioeconomic development, vulnerability index, and maternal mortality in Brazil, 2017. BMC Public Health. 2021;21:1842. DOI: 10.1186/s12889-021-11861-y
    Back to article
  20. 20Nascimento BR, Beaton AZ. Rheumatic heart disease and socioeconomic development. Lancet Glob Health. 2019;7(10):e1297–e1299. DOI: 10.1016/S2214-109X(19)30369-9
    Back to article
  21. 21Brant LCC, Pinheiro PC, Passaglia LG, de Souza MFM, Malta DC, Banerjee A, et al. Cardiovascular mortality in Brazil during the COVID-19 pandemic: a comparison between underlying and multiple causes of death. Public Health. 2023;224:131–139. DOI: 10.1016/j.puhe.2023.08.027
    Back to article
  22. 22Lopes EL, Beaton AZ, Nascimento BR, Tompsett A, Dos Santos JP, Perlman L, et al. Telehealth solutions to enable global collaboration in rheumatic heart disease screening. J Telemed Telecare. 2018;24(2):101–109. DOI: 10.1177/1357633X16677902
    Back to article
  23. 23Santos JPAD, Carmo GAL do, Beaton AZ, Lourenço TV, Diamantino AC, Nunes M do CP, et al. Challenges for the implementation of the first large-scale rheumatic heart disease screening program in Brazil: the PROVAR study experience. Arq Bras Cardiol. 2017;108(4):370–374. DOI: 10.5935/abc.20170047
    Back to article
  24. 24Oliveira KKB, Nascimento BR, Beaton AZ, Nunes MCP, Silva JLP, Rabelo LC, et al. Health education about rheumatic heart disease: a community-based cluster randomized trial: rheumatic heart disease educational strategies. Glob Heart. 2020;15(1):41. DOI: 10.5334/gh.347
    Back to article
  25. 25Nascimento BR, Nunes MCP, da Silva JLP, Steer A, Engelman D, Okello E, et al. Outcomes of latent rheumatic heart disease: external validation of a simplified score in patients with and without secondary prophylaxis. Int J Cardiol. 2024;399:131662. DOI: 10.1016/j.ijcard.2023.131662
    Back to article
  26. 26Nascimento BR, Beaton AZ, Nunes MCP, Diamantino AC, Carmo GAL, Oliveira KKB, et al. Echocardiographic prevalence of rheumatic heart disease in Brazilian schoolchildren: data from the PROVAR study. Int J Cardiol. 2016;219:439–445. DOI: 10.1016/j.ijcard.2016.06.088
    Back to article
  27. 27Nascimento BR, Sable C, Nunes MCP, Diamantino AC, Oliveira KKB, Oliveira CM, et al. Comparison between different strategies of rheumatic heart disease echocardiographic screening in Brazil: data from the PROVAR (Rheumatic Valve Disease Screening Program) Study. J Am Heart Assoc. 2018;7(4):e008039. DOI: 10.1161/JAHA.117.008039
    Back to article
  28. 28Nascimento BR, Sable C, Nunes MCP, Oliveira KKB, Franco J, Barbosa MM, et al. Echocardiographic screening of pregnant women by non-physicians with remote interpretation in primary care. Fam Pract. 2021;38(3):225–230. DOI: 10.1093/fampra/cmaa115
    Back to article
  29. 29Araujo RS, Souza ASS de, Braga JU. Who was affected by the shortage of penicillin for syphilis in Rio de Janeiro, 2013–2017? Rev Saude Publica. 2020;54:109. DOI: 10.11606/s1518-8787.2020054002196
    Back to article
  30. 30GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100–2132. DOI: 10.1016/S0140-6736(24)00367-2
    Back to article
  31. 31GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162–2203. DOI: 10.1016/S0140-6736(24)00933-4
    Back to article
DOI: https://doi.org/10.5334/gh.1504 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Jan 12, 2025
Accepted on: Nov 25, 2025
Published on: Dec 10, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
rheumatic heart disease,
cardiovascular epidemiology,
Brazil

© 2025 Pedro Rafael Vieira de Oliveira Salerno, Antoinette Cotton, Zhou Chen, Vaibhav Shah, Gabriel Tensol Rodrigues Pereira, Sadeer Al-Kindi, Craig Sable, Antonio Luiz Pinho Ribeiro, Andrea Z. Beaton, Salil V. Deo, Bruno Ramos Nascimento, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 20 (2025): Issue 1